Stöger Lab
Dynamics of Pulmonary InflammationWe want to understand the circumstances that impair pulmonary inflammation in a way to cause a long-term damage of the lung. Our goals are therapeutic nanoparticles for pulmonary application and the respiratory safety of engineered nanoparticles.
We want to understand the circumstances that impair pulmonary inflammation in a way to cause a long-term damage of the lung. Our goals are therapeutic nanoparticles for pulmonary application and the respiratory safety of engineered nanoparticles.
Publications
2023 Front Immunol.
2022 Int J Mol Sci.
2020 Advanced Materials
2017 Part Fibre Toxicol.
2017 Part Fibre Toxicol.
Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection